Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

PPHvsMEDXETF Comparison

ETF 1
PPH

VanEck Pharmaceutical ETF

This fund is part of
Uncategorized Equities
-0.85%
VS
ETF 2
MEDX

Horizon Kinetics Medical ETF

This fund is part of
Tomorrow's Treatments
-0.65%

VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. Horizon Kinetics Medical ETF (MEDX) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Healthcare. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.85% for MEDX. PPH is up 8.75% year-to-date (YTD) with -$377M in YTD flows. MEDX performs worse with 6.77% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of PPH and MEDX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PPH vs MEDX performance and flow charts

Performance

-2.00.02.04.06.08.0%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

-60,000,000-40,000,000-20,000,000020,000,000Jun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
PPH
MEDX
+5.25%+1.04%
+10.99%+10.61%
+8.75%+6.77%
+26.11%+27.70%
+45.51%+26.13%
+65.20%n/a
Flows
PPH
MEDX
+$15M-$883K
-$106M-$2M
-$377M-$3M
+$257M-$3M
+$353M-$4M
+$396M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
PPH
MEDX
+20.60%+20.98%
+18.27%+18.56%
+15.75%+17.30%
+15.33%n/a
Max drawdown
PPH
MEDX
-4.39%-7.93%
-10.78%-10.65%
-17.98%-23.05%
-20.19%n/a
Max drawdown duration
PPH
MEDX
17d17d
122d115d
434d393d
484dn/a
Trading data

Create an account to view trading data

Join for free
PPH
MEDX
Last sale
7/27/2026 at 1:30 PM
$111.31
$35.58
Previous close
07/24/2026
$110.63
$35.49
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

MEDX
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
PPH
MEDX
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
PPH
MEDX
Last price
$111.31
$35.58
1D performance
+0.61%
+0.25%
AuM$960.98 M$17.57 M
E/R0.36%0.85%
Characteristics
PPH
MEDX
Management strategyPassiveActive
ProviderVanEckHorizon Kinetics LLC
BenchmarkMVIS US Listed Pharmaceutical 25 Index-
N° of holdings2530
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateDecember 20, 2011January 27, 2023
ESGNoNo
Advertisement
Exposure

Countries

PPH
USA
61.03%
United Kingdom
11.84%
Switzerland
10.63%
Other
16.49%
MEDX
USA
68.17%
Switzerland
10.22%
United Kingdom
8.49%
Other
13.12%

Sectors

PPH
Healthcare
100%
MEDX
Healthcare
92.67%
Other
7.33%
Advertisement

Diversification

PPH

Total weight of top 15 holdings out of 15

90.85%
MEDX

Total weight of top 15 holdings out of 15

81.88%

Top 15 holdings

Data as of June 30, 2026
PPH
Eli Lilly & Co.
20.64%
Novartis AG
10.63%
Merck & Co., Inc.
9.86%
Novo Nordisk A/S
5.38%
AbbVie, Inc.
4.60%
Pfizer Inc.
4.54%
Bristol Myers Squibb Co.
4.52%
GSK Plc
4.43%
Johnson & Johnson
4.41%
AstraZeneca PLC
4.34%
McKesson Corp.
4.06%
Sanofi
4.06%
Cencora, Inc.
3.32%
Haleon Plc
3.08%
Teva Pharmaceutical Industries Ltd.
2.99%
MEDX
Eli Lilly & Co.
18.51%
AbbVie, Inc.
8.87%
Novartis AG
6.80%
Alkermes Plc
5.79%
Johnson & Johnson
5.58%
AstraZeneca PLC
4.93%
Ionis Pharmaceuticals, Inc.
4.62%
Bristol Myers Squibb Co.
4.40%
Merck & Co., Inc.
3.94%
Amgen, Inc.
3.86%
Alnylam Pharmaceuticals, Inc.
3.30%
Biogen, Inc.
3.07%
Pfizer Inc.
2.87%
GSK Plc
2.70%
CRISPR Therapeutics AG
2.64%
Frequently asked questions about PPH and MEDX

How have the PPH and MEDX ETFs performed in 2026?

As of July 24, 2026, PPH is up 8.75% year-to-date (YTD), while MEDX has returned 6.77%. That puts PPH better performer ahead so far this year.

Which ETF is attracting more investor money: PPH or MEDX?

Year-to-date, the PPH ETF saw -$377M in flows, compared to -$3M for MEDX.

Which ETF is more volatile: PPH or MEDX?

Over the past year, PPH had a volatility of 18.27%, while MEDX experienced 18.56%.

Which ETF is bigger: PPH or MEDX?

As of July 24, 2026, PPH holds $960.98 M in assets under management (AUM), while MEDX manages $17.57 M.

What sectors do the PPH and MEDX ETFs invest in?

PPH leans toward sectors like Healthcare. Meanwhile, MEDX focuses on Healthcare.

What are the top holdings of the PPH ETF and MEDX ETF?

PPH top holdings include Eli Lilly & Co., Novartis AG and Merck & Co., Inc.. MEDX holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Novartis AG.

Which ETF is more diversified: PPH or MEDX?

PPH holds 25 securities with 90.85% of its assets in the top 15. MEDX has 30 securities and a top 15 weight of 81.88%.

Advertisement
Latest news about PPH & MEDX
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026